Ectopic expression of transcription factors is sufficient to override stable epigenetic programs and hence alter cell fate 1 . For example, forced expression of the pluripotency-related transcription factors Oct4, Klf4, Sox2 and c-Myc (OKSM) in somatic cells yields iPS cells, which are molecularly and functionally equivalent to embryonic stem cells (ES cells) 2 . Similarly, ectopic expression of lineage-specific transcription factors drives conversion of heterologous cells into cardiac, neuronal, myeloid and other specialized cell types 3 . However, the reprogramming process is generally slow and inefficient, suggesting that chromatinassociated mechanisms are in place to safeguard somatic cell identity and confer resistance to cell-fate change.
Ectopic expression of transcription factors is sufficient to override stable epigenetic programs and hence alter cell fate 1 . For example, forced expression of the pluripotency-related transcription factors Oct4, Klf4, Sox2 and c-Myc (OKSM) in somatic cells yields iPS cells, which are molecularly and functionally equivalent to embryonic stem cells (ES cells) 2 . Similarly, ectopic expression of lineage-specific transcription factors drives conversion of heterologous cells into cardiac, neuronal, myeloid and other specialized cell types 3 . However, the reprogramming process is generally slow and inefficient, suggesting that chromatinassociated mechanisms are in place to safeguard somatic cell identity and confer resistance to cell-fate change.
Previous efforts to identify chromatin modulators of iPS cell formation included gain-and loss-of-function screens, as well as transcriptional profiling of bulk or FACS-enriched cell populations undergoing reprogramming. However, iPS cell modulators that do not change transcriptionally are typically overlooked when analysing expression dynamics in reprogramming intermediates 4 . Moreover, known repressors of iPS cell formation such as p53, Mbd3, Dot1l and Dnmt1 were either predicted or identified from small candidate sets and some of these molecules appear to depend on specific cell contexts or culture conditions [5] [6] [7] . Although large-scale RNAi screens have been used to systematically probe roadblocks to reprogramming 4, 8, 9 , this approach remains technically challenging due to the lack of effective short hairpin RNAs (shRNAs), prevalent off-target effects, and biases in the library representation or the screening readout. We therefore hypothesized that additional barriers to iPS cell formation remain to be discovered and should yield insights into mechanisms that safeguard somatic cell identity.
To systematically explore chromatin factors that resist transcriptionfactor-induced cell-fate transitions, we used custom microRNA-based shRNA libraries targeting known and predicted chromatin regulators in two independent screening strategies during the reprogramming of fibroblasts into iPS cells. Both screens validated previously implicated chromatin pathways and revealed novel, potent repressors of reprogramming. Through a series of cellular and molecular studies, we found that suppression of a histone chaperone complex markedly enhanced and accelerated iPS cell formation by influencing local chromatin accessibility, transcription factor binding and histone H3K9 trimethylation (H3K9me3). We propose that this complex functions as a key determinant of cellular identity by resisting transcription-factor-induced cell-fate change.
Cellular differentiation involves profound remodelling of chromatic landscapes, yet the mechanisms by which somatic cell identity is subsequently maintained remain incompletely understood. To further elucidate regulatory pathways that safeguard the somatic state, we performed two comprehensive RNA interference (RNAi) screens targeting chromatin factors during transcription-factor-mediated reprogramming of mouse fibroblasts to induced pluripotent stem cells (iPS cells). Subunits of the chromatin assembly factor-1 (CAF-1) complex, including Chaf1a and Chaf1b, emerged as the most prominent hits from both screens, followed by modulators of lysine sumoylation and heterochromatin maintenance. Optimal modulation of both CAF-1 and transcription factor levels increased reprogramming efficiency by several orders of magnitude and facilitated iPS cell formation in as little as 4 days. Mechanistically, CAF-1 suppression led to a more accessible chromatin structure at enhancer elements early during reprogramming. These changes were accompanied by a decrease in somatic heterochromatin domains, increased binding of Sox2 to pluripotency-specific targets and activation of associated genes. Notably, suppression of CAF-1 also enhanced the direct conversion of B cells into macrophages and fibroblasts into neurons. Together, our findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.
RNAi screens for chromatin barriers to reprogramming
We conceived two parallel strategies for screening chromatinfocused microRNA-based shRNA (shRNAmiR) libraries in transgenic ('reprogrammable') mouse embryonic fibroblasts (MEF) harbouring a doxycycline-inducible polycistronic OKSM cassette and a constitutive M2rtTA driver 10 . We first designed an arrayed screening strategy using a previously described miR-30-based retroviral shRNA library targeting 243 genes 11 (1, 071 shRNAmiRs in pLMN vector) introduced one by one into reprogrammable MEFs ( Fig. 1a and Supplementary Table 1 ). Alkaline phosphatase-positive (AP + ), transgene-independent iPScell-like colonies were quantified using customized image analysis software after 12 days of doxycycline exposure and 5 days of doxycyclineindependent growth. Reprogramming efficiency ratios were calculated relative to a control shRNA targeting Renilla luciferase (Ren.713 (see Methods for details)).
In an independent multiplexed screen, we introduced an optimized miR-E-based 12 retroviral library targeting 615 known and predicted chromatin regulators (5, 049 shRNAmiRs in pLENC) ( Fig. 1b and Supplementary Table 2 ) into reprogrammable MEFs harbouring an Oct4-GFP reporter 10 . To control for biases due to background reprogramming events, we conducted parallel multiplex screens in a large number of biological replicates. Specifically, we transduced reprogrammable MEFs with the entire pool of 5,049 shRNAs in 48 biological replicates (>100 infected cells per shRNA and replicate) and induced OKSM expression 3 and 6 days after viral transduction to control for differences in target protein half-life, yielding 96 replicates in total (Fig. 1b) . Library representation was then quantified by deep sequencing of transgene-independent Oct4-GFP + iPS cells isolated by FACS, and strong shRNAmiRs were identified using an additive score reflecting the consistency of shRNA enrichment across all replicates. Article reSeArcH
Nucleosome assembly factor blocks iPS cell formation
Remarkably, despite methodological differences, the most prominent hits that emerged from both screens were Chaf1a and Chaf1b, two subunits of the chromatin assembly factor complex CAF-1 involved in the deposition of canonical histones H3/H4 on newly synthesized DNA 13 (Fig. 1c-e and Supplementary Tables 1 and 2 ). Additional hits of interest included the SUMO-conjugating enzyme Ube2i, a novel repressor of iPS cell formation, as well as the SET domain-containing H3K9 methyltransferase Setdb1, which has previously been shown to inhibit reprogramming [14] [15] [16] . Importantly, the top-scoring shRNAs targeting Chaf1a, Chaf1b, or Ube2i reduced the expression of their predicted target genes (Fig. 1f , Extended Data Fig. 1a-d and Supplementary Fig. 1 ).
We validated enhanced reprogramming with top-scoring shRNAs from the multiplexed screen ( Fig. 1g and Supplementary Table 2 ). Although reprogramming efficiency increased from 0.5% in controls to 1-5% with Trp53 shRNAs, consistent with previous reports 17 , Chaf1a, Chaf1b, or Ube2i suppression robustly enhanced reprogramming efficiency up to 20-60%, regardless of culture conditions ( Fig. 1g and Extended Data Fig. 1e , f). shRNAs targeting Sae1 and Uba2a, which are components of the SUMO E1 ligase complex, mirrored the effects of Ube2i suppression on reprogramming (Extended Data Fig. 1g ), further validating the sumoylation pathway as a major repressor of iPS cell formation.
We next used a doxycycline-inducible shRNAmiR expression system to test whether transient suppression of Chaf1a, Chaf1b or Ube2i during reprogramming affected the ability of the resultant iPS cells to contribute to normal development. shRNAs and OKSM were simultaneously expressed in reprogrammable MEFs for 7 days. Oct4-GFP + cells were then purified using FACS, followed by doxycycline withdrawal to select for transgene-independent iPS cells. Injection of these iPS cells into blastocysts gave rise to adult high-grade chimaeras that efficiently produced germline offspring ( Fig. 2a and Extended Data Fig. 2a ). These results indicate that silencing of Chaf1a, Chaf1b or Ube2i during reprogramming does not compromise the potential of iPS cells to differentiate into somatic and germ cell lineages in vivo.
Functional interactions of CAF-1, Ube2i and Setdb1
We next devised a combinatorial RNAi approach to assess whether the reprogramming barriers Chaf1a, Chaf1b, Ube2i and Setdb1 interact during iPS cell generation. Constitutive miR-E-based shRNA vectors targeting different pairs of chromatin regulators were sequentially transduced into reprogrammable MEFs, which were subsequently induced with doxycycline for 7 days. The transgene-independent fraction of reprogrammed cells at day 11 was then determined by flow cytometry and plotted as the ratio of Oct4-GFP + to Oct4-GFP − cells relative to an empty vector control (Fig. 2b, c and Extended Data Fig. 2b ). Co-suppression of two CAF-1 subunits, or of Setdb1 plus Chaf1a, Chaf1b or Ube2i impaired overall reprogramming efficiencies compared to suppression of each gene alone, although we cannot exclude that this phenotype is due to cellular toxicity elicited by potent suppression of these chromatin regulators. By contrast, simultaneous suppression of either CAF-1 subunit and Ube2i further increased reprogramming efficiency, suggesting that these factors may act in independent pathways or stages to repress iPS cell formation.
Suppression of CAF-1 accelerates iPS cell formation
To gain insights into the dynamics of reprogramming in the absence of the identified chromatin barriers, we followed the emergence of Oct4-GFP + cells over time. Although suppression of Ube2i promoted Oct4-GFP activation slightly earlier than controls (day 6 with Ube2i shRNA versus day 9 with Renilla shRNA), the suppression of either CAF-1 subunit triggered a dramatic acceleration of this process and consistently generated Oct4-GFP + cells as early as 5 days after OKSM expression ( Fig. 2d) . Similar effects were observed with analysis of Nanog expression ( Fig. 2e and Extended Data Fig. 2c ).
We next examined the ability of our candidate shRNAs to facilitate transgene-independent clonal growth, a hallmark of iPS cells. Suppression of either CAF-1 subunit or Ube2i gave rise to transgeneindependent Oct4-GFP + cells after 5 days of OKSM expression, the earliest examined time point, whereas stable iPS cells only appeared by day 9 in control shRNA-treated cells (Fig. 2f ). Examination of cell surface markers associated with different stages of reprogramming further showed that a larger fraction of Chaf1a shRNA vector-infected cells expressed the early intermediate marker Epcam at day 4 of iPS cell formation compared to controls, with a subset of cells activating the Oct4-tomato reporter (Fig. 2g ). Consistently, inhibition of Chaf1a consistently supported the formation of AP + , transgene-independent iPS cells after as little as 4 days of factor expression ( Fig. 2h ). Based on the notable effects of Chaf1a and Chaf1b suppression on the dynamics and efficiency of iPS cell formation, we focused subsequent analyses on these two components of the CAF-1 complex.
Figure 2 | CAF-1 suppression accelerates reprogramming and yields developmentally competent iPS cells. a,
Generation of iPS-cell-derived chimaeras using indicated shRNAmiRs. b, Combinatorial RNAi studies involving pairs of shRNAmiRs sequentially transduced 5 and 1 day before OKSM induction. Reprogramming efficiencies are shown as ratio of Oct4-GFP + to Oct4-GFP − cells at day 11 relative to an empty vector control. c, Flow cytometry plots of representative samples used for b. d, e, Time-course analysis of Oct4-GFP (d) and Nanog (e) expression during reprogramming of MEFs transduced with indicated shRNAmiRs. f, Establishment of transgene-independent Oct4− GFP + iPS cells in the presence of indicated shRNAmiRs (colour code as in d). Samples were induced with doxycycline for indicated number of days and analysed at day 13. g, Expression dynamics of reprogramming markers Epcam and Oct4-tomato after 4 and 6 days of OKSM expression (media supplemented with 2i, ascorbate and Dot1l inhibitor). h, Alkaline phosphatase (AP)-positive iPS cell colonies scored at day 11 after 4 or 6 days of OKSM expression (representative example from two biological replicates and three technical replicates). Suppression of CAF-1 subunits had no major effects on OKSM expression at the RNA or protein level, indicating that the observed phenotype is due to direct modulation of the reprogramming transgenes (Extended Data Fig. 3a -c and Supplementary Fig. 1 ). Moreover, the reprogramming increase elicited by Chaf1b shRNAs could be rescued by overexpression of an shRNA-resistant version of human CHAF1B cDNA, demonstrating specificity of the effect (Extended Data Fig. 3d ). Lastly, knockdown of either Chaf1a or Chaf1b did not increase cell proliferation in the presence of OKSM induction, indicating a growth-independent effect of CAF-1 suppression on reprogramming efficiency (Extended Data Fig. 3e , f).
Enhanced reprogramming requires optimal CAF-1 dosage
To determine whether the effect of CAF-1 on reprogramming depends on OKSM expression levels, we compared iPS cell formation between reprogrammable MEFs carrying either one (heterozygous) or two (homozygous) copies of the Col1a1::tetOP-OKSM and R26-M2rtTA alleles 10, 18 . Although CAF-1 suppression in heterozygous MEFs enhanced iPS cell formation by orders of magnitude, CAF-1 suppression in homozygous MEFs resulted in a more modest increase in iPS cell numbers ( Fig. 3a, b ). Accordingly, we observed that CAF-1 knockdown had a stronger effect on iPS cell derivation efficiency when infecting MEFs with viral vectors achieving moderate or transient OKSM expression compared to vectors achieving high OKSM expression ( Fig. 3c, d and Extended Fig. 4a -e). These results show that the reprogramming phenotype induced by CAF-1 suppression is influenced by both the levels and the duration of OKSM expression.
CAF-1 is essential for embryonic growth and viability of cultured cells in the absence of exogenous OKSM expression [19] [20] [21] [22] , which we confirmed in NIH3T3 cells using the strongest CAF-1 shRNAs (Extended Data Fig. 5a ). To test whether the duration and degree of CAF-1 suppression might affect reprogramming efficiency, we generated transgenic MEFs carrying a doxycycline-inducible Chaf1a shRNA linked to an RFP reporter in the Col1a1 locus ( Fig. 3e ). Infection of transgenic MEFs with a constitutive lentiviral vector expressing OKSM in the presence of low doses of doxycycline (0.2 µg ml −1 ) for 2-9 days resulted in a progressive increase in the formation of Nanog + iPS cell colonies, which plateaued by day 6 ( Fig. 3e and Extended Data Fig. 5b-d ). By contrast, exposure of replicate cultures to high doses of doxycycline (2 µg ml −1 ) increased reprogramming efficiency until day 4 but decreased iPS cell colony numbers thereafter. These data suggest that enhanced reprogramming is also dependent on CAF-1 dose, with early CAF-1 suppression being beneficial but long-term, potent suppression being detrimental to iPS cell derivation.
To investigate whether genomic perturbation of CAF-1 components mimics the phenotype elicited by shRNAs, we introduced mutations into the endogenous Chaf1a locus using CRISPR/Cas9 technology. Briefly, reprogrammable MEFs were transduced with lentiviral vectors expressing Cas9 and two independent single-guide RNAs (sgRNAs) targeting the C-terminal PCNA interaction domain, which is essential for chromatin assembly 23 . Strikingly, treatment of MEFs with Cas9 and sgRNAs resulted in a similar increase in reprogramming efficiency as shRNA treatment, indicating that genetic perturbation of the endogenous Chaf1a locus phenocopies the effect of Chaf1a shRNAs ( Fig. 3f ). Sequencing of Chaf1a sgRNA-induced modifications revealed the presence of mostly biallelic (24/34) and to a lesser extent monoallelic (10/34) genome edits, suggesting that complex alterations of the Chaf1a coding region on one or both chromosomes can lead to hypomorphic alleles that promote iPS cell generation (Extended Data Fig. 5e ). Indeed, analysis of representative iPS cell clones showed a consistent reduction but no complete loss of total Chaf1a and Chaf1b protein levels (Extended Data Fig. 3f and Supplementary Fig. 1 ).
Collectively, these findings demonstrate that the observed reprogramming phenotype is dependent on the duration and levels of both CAF-1 and OKSM and that this effect can be recapitulated with multiple experimental paradigms.
CAF-1 depletion enhances direct lineage conversion
To investigate whether CAF-1 acts as a gatekeeper of cellular identity across different cell types, we tested the effect of Chaf1a knockdown on the reprogramming potential of haematopoietic stem and progenitor cells (HSP cells) isolated from fetal livers of reprogrammable mice ( Fig. 4a ). Although HSP cells expressing Renilla shRNA gave rise to 56% and 76% Pecam + iPS-cell-like cells at days 4 and 6, respectively, suppression of Chaf1a using two independent shRNAs facilitated reprogramming towards a Pecam + state in 90% of cells at day 4 and 97% at day 6 (Extended Data Fig. 6a, b ). Chaf1a knockdown cells also showed a striking elevation of Pecam expression levels at both time points, consistent with acquisition of a fully reprogrammed iPS cell state (Fig. 4b, c ). Accordingly, suppression of Chaf1a gave rise to more transgene-independent colonies compared to controls (Extended Data Fig. 6c ).
To assess whether CAF-1 stabilizes somatic cell identity in cell-fate conversion systems other than OKSM-mediated reprogramming, we first examined transdifferentiation of fibroblasts into induced neurons upon overexpression of the transcription factor Ascl1 C h a f 1 a .3
in MEFs 24 . Transgenic MEFs harbouring doxycycline-inducible shRNAs targeting Renilla luciferase or Chaf1a in the Col1a1 locus (see Fig. 3e ) were transduced with a doxycycline-inducible Ascl1expressing lentivirus and measured for induced neuron formation at day 13 ( Fig. 4d ). CAF-1 knockdown consistently resulted in a twofold increase (P = 0.0075) in the number of Map2 + neurons (Fig. 4e , f and Extended Data Fig. 6d ). We next tested the effect of CAF-1 suppression during the conversion of pre-B cells into macrophages upon overexpression of the myeloid transcription factor C/EBPα (Fig. 4g ). Consistent with a previous study 25 , we found that the myeloid markers Cd14 and Mac1 are activated in the majority of cells after 48 h of C/EBPα expression (Extended Data Fig. 6e-g) . Remarkably, shRNA suppression of CAF-1 markedly increased Cd14 and Mac1 expression levels at two different time points ( Fig. 4h , i) as well as the fraction of Mac1 + and Cd14 + cells after 24 h of C/EBPα induction (Extended Data Fig. 6e-g) .
Together, these data indicate that CAF-1 suppression not only enhances the induction of pluripotency from different cell types but also facilitates cellular transdifferentiation, suggesting that CAF-1 may play a more general role in resisting transcription-factor-induced cellfate conversions.
CAF-1 influences chromatin accessibility
As CAF-1 functions as a histone chaperone 13 , we reasoned that its reduction may result in a more accessible chromatin structure and thus facilitate transcription factor binding to their target loci. To test this possibility, we first performed sonication of crosslinked chromatin sequencing (SONO-seq) analysis, which determines accessible chromatin regions based on their increased susceptibility to sonication 26 . We analysed bulk cultures expressing OKSM for 3 days when stable iPS cells are not yet present (Extended Data Fig. 7a ), focusing on EScell-specific regulatory elements. Although ES-cell-specific promoter elements showed no discernible difference in accessibility (P = 0.51), we observed a significant enrichment of SONO-seq signal at ES-cellspecific enhancer elements in CAF-1 depleted cells at day 3 of OKSM expression (Extended Fig. 7b ; P < 2.6 × 10 −12 ).
To validate these observations with an independent, higher resolution method, we performed assay of transposase accessible chromatin-sequencing (ATAC-seq), which detects integration of the Tn5 transposase in open chromatin regions 27 (Extended Data Fig. 7c ). Consistent with the SONO-seq data, ATAC-seq analysis of early reprogramming intermediates showed a more accessible chromatin configuration at regulatory regions including ES-cell-specific enhancers upon suppression of Chaf1a ( Fig. 5a ; P value < 10 −15 ). Moreover, Chaf1a knockdown caused a significant increase in chromatin accessibility across ES-cell-specific super-enhancers at day 3 of iPS cell formation ( Supplementary Table 3 and Extended Data Fig. 7d , e; P < 5.3 × 10 −16 ). Of note, super-enhancers linked to specialized cell types such as macrophages, lymphocytes and muscle cells were also significantly more accessible in Chaf1a depleted reprogramming intermediates compared to controls (Extended Data Fig. 7f ). Taken together, these results suggest that CAF-1 suppression increases the permissiveness of cells to transcription-factor-induced cell-fate change by facilitating a more accessible local chromatin structure at enhancer elements.
Next, we performed ChIP-seq analysis for Sox2 at day 3 of OKSM expression in order to test our hypothesis that increased chromatin accessibility at enhancer elements influences reprogramming factor binding. Indeed, we detected an increase in Sox2 binding to EScell-specific regulatory elements in Chaf1a shRNA-treated cells compared to controls ( Fig. 5b and Extended Data Fig. 8a ). Approximately 90% of Sox2 binding sites were shared between Chaf1a knockdown and control cells, whereas 10% were unique to cells expressing either Chaf1a shRNA or Renilla shRNA (Extended Data Fig. 8b ). Although Chaf1a knockdown cells showed slightly fewer unique Sox2 binding sites than Renilla knockdown cells, these sites were enriched for ES-cell-specific Sox2 targets (Extended Data Fig. 8c ) and EScell-specific super-enhancer elements ( Supplementary Table 4 ). Of the Sox2-bound super-enhancers unique to CAF-1 knockdown cells, a subset also showed a more accessible chromatin structure by ATAC-seq analysis (for example, Sall1; Fig. 5c and Supplementary  Table 4 ). Notably, Sox2 binding was also increased across lineagespecific super-enhancers when comparing Chaf1a knockdown cells to control at day 3 of reprogramming, consistent with the observed increase in chromatin accessibility at these elements (Extended Data Figs 7f and 8d).
Collectively, these results indicate that loss of CAF-1 contributes to reprogramming, at least in part, by increasing chromatin accessibility at pluripotency-specific enhancer elements and by promoting the binding of Sox2 to ES-cell-specific targets. 
CAF-1 affects heterochromatin and gene expression
Considering that CAF-1 plays crucial roles not only in histone exchange but also heterochromatin maintenance 19, 21, 28 , we next examined the global distribution of the heterochromatin mark H3K9me3 during reprogramming in the presence of either Chaf1a or Renilla shRNAs. We did not detect significant differences in H3K9me3 levels across pluripotency-associated enhancers or transposable elements, which are typically silenced by H3K9me3 modifications (Extended Data Fig. 9a, b ). Likewise, RNA-seq analysis of the same intermediates failed to show differential expression of transposable elements (Extended Data Fig. 9c ). However, we detected a local depletion of H3K9me3 at a subset of somatic heterochromatin areas termed 'reprogramming-resistant regions' , which have recently been linked to the low efficiency of somatic cell nuclear transfer (SCNT) 29 ( Fig. 5d and Extended Data Fig. 9d, e ). These data suggest that CAF-1 inhibition, in concert with OKSM expression, causes local changes in this key repressive histone modification, which may prime chromatin structure for efficient transcriptional activation. MEFs expressing OKSM and Chaf1a shRNAs upregulated a number of pluripotency-related genes (for example, Utf1, Epcam, Nr0b1, Tdgf1 and Sall4) at day 6 of reprogramming compared to the Renilla shRNA control ( Supplementary Table 5 ). Although these genes were not yet differentially expressed at day 3 of reprogramming (data not shown), chromatin associated with these genes was already more accessible, supporting the view that CAF-1 suppression may prime the genome for subsequent transcriptional activation ( Fig. 5e ). To exclude that transcriptional activation of these pluripotency genes is an indirect consequence of accelerated reprogramming following CAF-1 suppression, we performed a 'chromatin in vivo assay' (CiA) 30 . Specifically, we introduced CAF-1 or control shRNAs into transgenic fibroblasts carrying an array of Gal4 binding sites (UAS elements) upstream of the endogenous Oct4 promoter and a GFP reporter in place of the Oct4 coding region. Although expression of Gal4-VP16 alone or in combination with a control shRNA triggered weak Oct4-GFP activation, co-expression of Gal4-VP16 and independent shRNAs targeting Chaf1a or Chaf1b strongly enhanced GFP expression from the somatically silenced Oct4 locus ( Fig. 5f and Extended Data Fig. 9f ). These results demonstrate that CAF-1 suppression enhances the direct transcriptional activation of the endogenous Oct4 locus independently of OKSM-induced cell-fate changes.
Discussion
We find that CAF-1 suppression not only enhances reprogramming towards pluripotency but also direct lineage conversion, suggesting that the study of iPS cell formation may be a valuable approach to uncover general mechanisms that safeguard somatic cell identity. Importantly, enhanced reprogramming is influenced by the degree and duration of CAF-1 suppression, consistent with the essential role of CAF-1 during cellular growth 19, 20, 22 . The identification of dose-dependent regulators of reprogramming highlights the utility of RNAi screens to achieve hypomorphic gene expression states, allowing for the detection of phenotypes that might not have been observed with complete and permanent ablation of genes. However, suboptimal reduction of CAF-1 levels may also explain our inability to detect a consistent enhancement of iPS cell formation upon CAF-1 suppression in preliminary human reprogramming experiments (data not shown). Similarly, variable CAF-1 gene dosage may account for phenotypic differences between our study and previous publications examining the function of CAF-1 in ES cells 21, 31 . Suppression of CAF-1 in ES cells reportedly results in a decondensation of pericentric heterochromatin, the reactivation of transposable elements and cell cycle arrest and apoptosis, which differs from our observations in nascent iPS cells. An alternative explanation is that cell-intrinsic differences between early reprogramming intermediates and established pluripotent cells cause distinct phenotypes 21 .
It is possible that other histone chaperones compensate for reduced CAF-1 levels, thereby contributing to the observed reprogramming phenotype. In support of this notion, suppression of the CAF-1 p60 subunit in HeLa cells triggers alternative deposition of the histone variant H3. 3 (ref. 32 ). Of interest, H3.3 deposition on chromatin has been associated with enhanced reprogramming in the context of SCNT 33,34 , suggesting parallels between the processes of cloning and iPS cell generation. Our finding that CAF-1 suppression leads to specific loss of H3K9me3 at reprogramming-resistant regions supports this notion. The recent insight that CAF-1 siRNA-treated ES cells revert towards a two-cell-like embryonic state more amenable to reprogramming by SCNT is consistent with this conclusion and ChIP-seq analysis of ES-cell-specific enhancers and promoters at day 3 of reprogramming using weak (shRNA no. 2120) and strong (shRNA no. 164) Chaf1a hairpin (P < 1 × 10 −15 for both shRNAs; see a for definition of n). c, Representative ATAC-seq and Sox2 ChIP-seq peaks at the Sall1 superenhancer (y axis: tag density profiles). d, H3K9me3 ChIP-seq analysis of reprogramming-resistant regions (RRRs) 29 after 0 and 3 days of OKSM expression. Heatmap shows all RRRs (rows); box plots show individual RRRs between day 0 and 3 in Chaf1a knockdown cells (P < 0.05 for both shRNAs). e, Chromatin accessibility at days 0, 3 and 6 for genes that become transcriptionally upregulated in Chaf1a shRNA-treated cells by day 6 (*P < 0.05; * *P < 0.01). f, Chromatin in vivo assay (CiA) to directly measure effect of CAF-1 suppression on transcriptional activity of endogenous Oct4 locus in fibroblasts upon overexpression of Gal4-VP16 fusion protein targeted to the Oct4 promoter. g, Summary and model. TF, transcription factor; Pol II, RNA polymerase II.
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reinforces the view that CAF-1 may act as a general stabilizer of cell identity 31 . We propose a model whereby CAF-1 contributes to the maintenance of somatic cell identity by stabilizing chromatin patterns ( Fig. 5g ). Here, suppression of CAF-1 would trigger dilution of newly assembled nucleosomes at key enhancer elements and loosening of chromatin structure in conjunction with forced expression of celltype-specific transcription factors. These combined changes would generate an accessible chromatin landscape for efficient transcription factor binding and activation of key target genes.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
MethOdS Data reporting. No statistical methods were used to predetermine sample size. The investigators were not blinded to allocation during experiments and outcome assessment. One cell line 25 was used (subclone C10) in this study. Cell line identity was verified by its responsiveness to tamoxifen, resulting in conversion of cells into macrophages (quantified by surface marker expression of Mac1 and Cd14). Cells were tested for mycoplasma contamination and found to be negative. Plasmids. For the pooled RNAi screen, shRNAs were expressed from the LENC vector, which has been described previously 12 . For the primary screen validation, timeline experiment and immunofluorescence staining, mouse shRNAs were cloned individually into LENC. For the double knockdown experiment, shRNAs were cloned into LEPC (MSCV-mirE-PGK-Puro-IRES-mCherry).
For the reprogramming dynamics experiment and chimaera mouse production, shRNAs were cloned into RT3CEPIN (TRE3G-mCherry-mirE-PGK-Puro-IRES-Neo). For reprogramming experiments with non-transgenic systems, previously published OKSM lentiviral vectors were modified to introduce promoters of different strength, which are described in the main figures. Cell culture and media. Packaging cells (Platinum-E Retroviral Packaging Cell Line) for producing retroviral particles were cultured in DMEM supplemented with 15% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM) and l-glutamine (4 mM) at 37 °C with 5% CO 2 . Mouse embryonic fibroblasts (MEF) were cultured in DMEM supplemented with 15% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), l-ascorbic acid (50 µ M) at 37 °C with low oxygen (4.5% O 2 ). iPS cells were derived in DMEM supplemented with 15% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), 1,000 U ml −1 LIF, 0.1 mM beta-mercaptoethanol, and 50 µ g ml −1 ascorbic acid at 37 °C with 5% CO 2 and 4.5% O 2 . For Tet-inducible OKSM expression, doxycycline was added at a concentration of 1 µg ml −1 (unless indicated otherwise). iPS cells for blastocyst injection were cultured on feeders in DMEM supplemented with 13% knockout serum replacement (Gibco), 2% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), l-ascorbic acid (50 µ M), 1000 U ml −1 LIF, beta-mercaptoethanol (50 µM), MEK inhibitor (PD0325901, 1 µ M) and GSK3 inhibitor (CHIR99021, 3 µ M) at 37 °C with 5% CO 2 . Conventional reprogramming media consisted of DMEM supplemented with 15% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), 1,000 U ml −1 LIF, 0.1 mM beta-mercaptoethanol unless otherwise noted. For some experiments, media was supplemented with MEK inhibitor (1 µ M), GSK3 inhibitor (3 µ M), Dot1l inhibitor (1 µ M) or ascorbate (50 µ g ml −1 ). Reprogrammable MEFs containing either one or two copies of the Col1a1::tetOP-OKSM, Oct4-GFP and Rosa26 M2rtTA alleles 10 were derived from E13.5 embryos. MEFs were prepared after carefully excluding internal organs, heads, limbs and tails. Tissues were chopped into small clumps using scalpels and trypsin and subsequently expanded in MEF medium at low O 2 (4%). MEFs were frozen at passage 0 upon derivation and used at passages 1-3 for all downstream transduction and reprogramming experiments. MEFs were generally cultured at low O 2 (4%) and supplemented with ascorbate to prevent replicative senescence before OKSM induction. Reprogramming experiments were initiated at low oxygen levels during doxycycline induction and completed at normal oxygen levels (20%) for experiments using miR-E vectors. MiR-30 assays were performed under normal oxygen levels. To generate Col1a1::tetOP-miR30-tRFP-Ren.713 and Col1a1::tetOP-miR30-tRFP-Chaf1a.164 shRNA knock-in MEFs, miR30-based shRNAs targeting Chaf1a.164 or Ren.713 were cloned into a targeting vector as previously described 35 except that the GFP reporter was replaced with a turbo RFP reporter. ES cells harbouring the R26-M2rtTA allele were targeted with these constructs and mice were generated by blastocyst injection. MEFs were harvested using standard protocols. HSP cells were isolated from fetal livers of the same mid-gestation reprogrammable transgenic embryos used for MEFs derivation, dissociated by vigorous pipetting with a 1 ml tip, filtered using a 35 µ m nylon mesh, followed by red blood cell lysis, and cultured in RPMI/FBS media supplemented with stem cell factor (SCF), IL3 and IL6 and transduced as indicated in the schematic (Fig. 4a ). Arrayed shRNA library preparation and screening. Single shRNA clones were picked from the master library at CSHL, arrayed in 12 × 96-well plates and sequence-verified individually using miR-30 backbone primers. An additional 200 unmatched clones were re-picked and sequenced to allow maximum coverage of the library. Reprogrammable MEFs carrying the OKSM inducible cassette and constitutive rtTA (Col1a1::tetOP-OKSM; R26-M2rtTA) were seeded at 10 4 cells per well in 96-well plates in duplicates and infected with the corresponding retroviral virus particles freshly produced and filtered. 48 h post-transduction, MEFs from each row of the 96-well plate were trypsinized and transferred to 6-well dishes coated with 0.2% gelatin in standard reprogramming media supplemented with doxycycline (2 µg ml −1 ) and G418 at 0.2 mg ml −1 for the first 6 days of OKSM expression. Doxycycline was withdrawn at day 12, allowing stable iPS cells to form. iPS cell colonies were then stained for alkaline phosphatase expression using the Vector Red Alkaline Phosphatase Substrate Kit (VectorLabs) according to the supplier's protocol, and plates were scanned using a Perfection V500 Photo scanner (Epson). To determine relative reprogramming efficiencies ( Fig. 1c and Supplementary Table 1 ), automated counting of iPS cell colonies was performed using the image-processing software CL-Quant (Nikon) and a custom algorithm provided by NIKON. Data were normalized to Ren.713 control. Pooled shRNA library preparation and screening. A miR-E-based chromatin library comprising 5,049 sequence-verified shRNAs targeting 615 known and predicted chromatin regulators was constructed by subcloning pools of sequence-verified miR-30 shRNAs into pLENC and combining them at equimolar concentrations into one pool 12 . This pool was transduced into MEFs carrying the Col1a1::tetOP-OKSM and R26-M2rtTA alleles, as well as a Pou5f1-EGFP reporter (termed Oct4-GFP) under conditions predominantly yielding a single retroviral integration in the genome. To generate a large number of independent biological replicates, primary MEFs from 4 triple transgenic embryos were transduced with the entire pool of 5,049 shRNAmiRs in 12 independent replicates at a representation of >100 cells per shRNA, yielding a total of 48 replicates (see Fig. 1b ). After 36 h, MEFs were treated with 0.5 mg ml −1 G418 for 3 days and 0.25 mg ml −1 G418 for an additional 3 days. MEFs from each replicate were plated at densities of 500,000 cells per 15 cm dish 3 or 6 days post-transduction, and induced with doxycycline (1 µg ml −1 ) for 7 days in medium containing serum and LIF, supplemented with ascorbate (50 µg ml −1 ). After passaging for an additional 4 days in doxycycline-free ES cell media, Oct4-GFP-expressing cells were sorted from each replicate using a FACSAriaIII (BD Bioscience).
Genomic DNA from infected MEFs (3d after infection) and sorted Oct4-GFP iPS cells from each replicate was isolated using proteinase K lysis, followed by two rounds of phenol extraction using PhaseLock tubes (5prime) and isopropanol precipitation. Templates for deep-sequencing were generated by PCR amplification of shRNA guide strands using primers that tag the product with standard Illumina adapters (p7+loop, CAAGCAGAAGACGGCATACGA[4-nt barcode]TAGTGAAGCCACAGATGT; p5+PGK, AATGATACGGCGACCACCGATGGATGTGGAATGTGTGC GAGG). For each sample, DNA was amplified in 12 parallel 50 µ l PCR reactions using Encyclo Polymerase (Evrogen). PCR products were combined for each sample, precipitated and purified on a 2% agarose gel. Samples were analysed on an Illumina High Seq 2500 and sequenced using a primer that reads in reverse into the guide strand (mirEEcoR1Seqprimer, TAGCCCCTTGAAGTCCGAGGCAGTAGGCA). Sequence processing was performed using a customized Galaxy platform. In all 96 iPS cell samples (48 biological replicates, 3 or 6 days knockdown before OKSM expression) the normalized reads of each shRNA were divided by the normalized reads in MEFs 3 days after viral transduction, and the resulting ratio was used to calculate a score for each shRNA in each replicate (default score = 0; score = 1 if ratio >1, score = 3 if ratio >10). Scores of each shRNA in 48 replicates were added separately for the day 3 and day 6 time point, yielding a sum score to estimate the overall enrichment of each shRNA over all replicates. All shRNA sequences and primary results from the arrayed and the multiplexed screen are provided in Supplementary Tables 1  and 2 , respectively. shRNAs are identified by numbers (e.g. Ren.713, Chaf1a.164), defined as the 5′ nucleotide of the guide binding site in the target transcript at the time of shRNA design.
Retrovirus production, transduction of MEFs and derivation of iPS cells.
Retroviral constructs were introduced into Platinium-E Retroviral Packaging cells using calcium phosphate transfection or lipofection as previously described 36 . shRNAs were transduced into primary MEFs carrying single copies of the Col1a1::tetOP-OKSM and R26-M2rtTA alleles as well as the Oct4-EGFP reporter. For some experiments, Oct4-tomato knock-in MEFs were used; the Oct4-tomato allele was generated equivalently to the Oct4-GFP allele 37 . For transduction, 180,000 cells were plated per well in a 6-well dish; all vectors were transduced in biological triplicate. After 36 h, transduced cells were selected with 0.5 mg ml −1 G418 for 3 days and 0.25 mg ml −1 G418 for an additional 3 days. Then 3 days after shRNA transduction, infected cells were washed with PBS (1×) and trypsinized with Trypsin-EDTA (1×) and 20,000 cells were plated into a 6-well. OKSM expression was induced for 7 days and cells were cultured in DMEM supplemented with 15% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), 1,000 U ml −1 LIF, 0.1 mM beta-mercaptoethanol, 50 µ g ml −1 sodium ascorbate and 1 µ g ml −1 doxycycline at 37 °C with low oxygen (4.5% O 2 ) and 5% CO 2 . After 7 days of OKSM expression, cells were cultured for an additional 4 days without doxycycline to withdraw OKSM transgene expression at 37 °C with 5% CO 2 , ambient oxygen. Following trypsinization, cells were analysed for Oct4-GFP expression using a FACS BD LSRFortessa (BD Biosciences), data were analysed using FlowJo.
Article reSeArcH
Phenotypic characterization of iPS cells. Alkaline phosphatase activity was measured using an enzymatic assay for alkaline phosphatase (VECTOR red alkaline phosphatase (AP) substrate kit) according to the manufacturer's protocol. Nanog immunohistochemistry of iPS cell colonies was performed as previously described 15 using anti-Nanog antibody (ab80892, Abcam) at a dilution of 1:500. Cells were permeabilized with 0.2% Triton-X before blocking and antibody incubation. Chimera production and germline transmission assays. Triple transgenic MEFs were reprogrammed as described, using a tetOP-inducible shRNAmiR expression vector RT3CEPIN (TRE3G-mCherry-mirE-PGK-Puro-IRES-Neo). Oct4-GFP + iPS cells generated with experimental shRNAs were sorted on day 7 of OKSM transgene expression. iPS cells were plated on feeders and cultured in DMEM supplemented with 13% knockout serum replacement, 2% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), l-ascorbic acid (50 µ M), 1,000 U ml −1 LIF, beta-mercaptoethanol, MEK inhibitor (PD0325901, 1 µ M) and GSK3 inhibitor (CHIR99021, 3 µ M) at 37 °C with 5% CO 2 . Polyclonally derived iPS cells were microinjected into B6 albino blastocysts to allow identification of chimaeras based on coat colour markers. Male chimaeras were mated to B6 albino females to allow identification of germline transmission based on coat colour. Double knockdown assay. Triple transgenic reprogrammable MEFs were transduced with shRNA expressed from LEPC as previously described and cultured in MEF media. 3 days after retroviral infection, cells were sorted for mCherry expression and 40,000 cells were re-plated per well of a 6-well dish. On the next day, cells were infected with the corresponding second shRNA expressed from LENC. 24 h later, cells were cultured in DMEM supplemented with 15% FBS, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, sodium pyruvate (1 mM), l-glutamine (4 mM), 1,000 U ml −1 LIF, 0.1 mM beta-mercaptoethanol and 1 µ g ml −1 , 50 µ g ml −1 sodium ascorbate, and 1 µ g ml −1 doxycycline at 37 °C with lox oxygen (4.5% O 2 ). 36 h after the second shRNA transduction, cell culture media was supplemented with 0.5 mg ml −1 G418 for 3 days and 0.25 mg ml −1 G418 for an additional 3 days to ensure double infection. After 7 days of OKSM transgene induction, cells were cultured in ES cell medium for an additional 4 days without doxycycline to select for transgene-independent colonies at 37 °C with 5% CO 2 . Cells were analysed for Oct4-GFP expression using a FACS BD LSRFortessa (BD Biosciences). The effect of double knockdown of targets on iPS cell formation was determined by calculating the ratio of Oct4-GFP + to Oct4-GFP − cells at day 11 relative to an empty vector control. Analysis of reprogramming dynamics. Triple transgenic reprogrammable MEFs carrying the Col1a1::tetOP-OKSM and R26-M2rtTA alleles as well as a Oct4-GFP reporter were reprogrammed in replicate wells as previously described. Starting on day 4 of OKSM transgene expression, cells were analysed for Oct-GFP expression in 24 h intervals using a BD LSRFortessa (BD Biosciences). In addition, 20% of cells were replated and cultured under doxycycline-free ES cell conditions. After 13 days, cells were analysed using a FACS BD LSRFortessa to determine the minimum time required for the establishment of transgene-independent iPS cells.
To determine Nanog expression dynamics, triple transgenic reprogrammable MEFs were reprogrammed in independent wells and analysed every 24 h. Starting on day 4 of OKSM transgene expression, cells were trypsinized with trypsin-EDTA (1×), washed with PBS (1×) and fixed with paraformaldehyde (PFA) (4%) for 30 min. Afterwards, cells were washed with PBS (1×) and stored at 4 °C. After 11 days of reprogramming, cells were stained with anti-Nanog antibody (rabbit polyclonal, 1:400, Abcam) and analysed using a FACS BD LSRFortessa (BD Biosciences).
Pecam staining of reprogramming intermediates was performed as previously described 18 . All samples were analysed on a MACSQuant fluorescence cytometer (Miltenyi). CRISPR/Cas9 editing of MEFs. sgRNAs targeting the Chaf1a locus were cloned into a lentiviral vector harbouring the wild type Cas9 coding region, an sgRNA expression cassette, and a Thy 1.1 reporter transgene. Successfully transduced cells were purified by FACS using Thy1.1 expression, cultured for 7 days to allow for genome editing to occur and induced with doxycycline for one week before measuring the fraction of Oct4-GFP + cells at day 11. Single Oct4-GFP + iPS cells were then plated to generate clonal iPS cell cultures for PCR amplification of CRISPR/Cas9-induced genomic modifications, followed by Sanger sequencing. sgRNAs were PCNA-1: GAAGCGCATTAAGGCAGAAA and PCNA-2: TTGGGAGCCTGCGGAGTCTT. Transdifferentiation assays. Induced neurons were generated as described in the experimental scheme (Fig. 4d ). CAF-1 or Renilla RNAi inducible transgenic MEFs were transduced with Ascl1-inducible lentivirus, exposed to doxycycline 24 h post-induction, cultured in MEF media for the first 48 h and switched to serum-free neuronal media (N3B27) supplemented with doxycycline for an additional 11 days. Cultures were fixed and stained for Map2 as previously described 24 .
Pre-B cells (C10 line) 25 were cultured in RPMI Medium, 10% charcoal stripped FBS (Invitrogen), 2 mM l-glutamine, 100 U ml −1 penicillin, 100 µ g ml −1 streptomycin, 55 µ M beta-mercaptoethanol. Pre-B cells were transduced with lentiviral pLKO vectors obtained from the Broad Insitute's RNAi consortium (empty vector 'null control' or vector carrying stem-loop shRNAs targeting Chaf1a and Chaf1b subunits). Following selection of transduced cells with puromycin, cells were seeded at 10 6 cells per ml and supplemented with oestradiol (E2) and macrophage cytokines (IL3 and CSF) to induce macrophage transdifferentiation as previously described 25 . All time points were analysed for Cd14 and Mac1 expression by flow cytometry on the same day. Quantitative RT-PCR. RNA was extracted (Qiagen RNeasy mini kit) and reverse transcribed (GE illustra ready-to-go RT-PCR beads) according to the supplier's instruction. Quantitative PCR was performed using SybrGreen and a BIO-RAD CFX connect cycler. Primers used were: b-Act-F: GCTGTATTCCCCTCCATCGTG; b-Act-R: CACGGTTGGCCTTAGGGTTCAG; Ube2i-R: GGCAAACT TCT TCGCT TGTGCTCGGAC; Ube2i-F: ATCCTTCTGGCACAGTGTGCCTGTCC; Chaf1b-R: GGCTCCTTGCTG TCATTCATCTTCCAC; Chaf1b-F: CACCGCCGTCAGGATCTGGAAGTTGG; Chaf1a-R: GTGTCTTCCTCAACTTTCTCCTTGG; Chaf1a-F: CGCGGAC AGCCGCGGCCGTGGATTGC.
SDS-PAGE and western blot analysis.
Whole-cell lysates from reprogramming intermediates were run on 4-20% gradient SDS-polyacrylamide gels and transferred to nitrocellulose membrane (Bio-Rad) by standard methods. Membranes were blocked for 1 h in 5% non-fat dry milk in 1 ×TBS with 0.05% Tween-20 (TBST), rinsed, and incubated with primary antibody diluted in 3% BSA in TBST overnight at 4 °C. The following primary antibodies were used: anti-Chaf1a (sc-10206, Santa Cruz), anti-Chaf1b (sc-393662, Santa Cruz), anti-TBP (ab818, Abcam), anti-Ube2i (4786, Cell signaling), anti-PCNA (D3H8P, Cell signaling), HRP conjugate anti-actin (AC-15, Sigma). Blots were washed in TBST, incubated with HRP-conjugated secondary antibodies for semi-quantitative western blot analysis and IRdye 800CW or IRdye 680RD for quantitative westerns, as indicated. Secondary antibodies for both methods were incubated in 5% milk in TBST for 1 h at room temperature (except for anti-β -actin-peroxidase antibody, which was incubated for 15 min), and washed again. HRP signal was detected by Enhanced ChemiLuminescence (Perkin Elmer). Fluorescent infrared signal was detected using LI-COR Odyssey imaging system. ATAC-seq chromatin assay. To generate ATAC-seq libraries, 50,000 cells were used and libraries were constructed as previously described 27 . Briefly, cells were washed in PBS twice, counted and nuclei were isolated from 100,000 cells using 100 µ l hypotonic buffer (10 mM Tris pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.1% NP40) to generate two independent transposition reactions. Nuclei were split in half and treated with 2.5 µ l Tn5 Transposase (Illumina) for 30 min at 37 °C. DNA from transposed nuclei was then isolated and PCR-amplified using barcoded Nextera primers (Illumina). Library quality control was carried out using high-sensitivity DNA bioanalyzer assay and qubit measurement and sequenced using paired-end sequencing (PE50) on the Illumina Hi-Seq 2500 platform.
SONO-seq and ChIP-seq chromatin assays. For all ChIP experiments, 107
reprogramming intermediates were collected per library. Chromatin precipitation assays were performed as previously described 38 using goat polyclonal anti-Sox2 antibody (AF2018, R&D). Briefly, cells were cross-linked on plate in 1% methanol-free formaldehyde and snap-frozen in liquid nitrogen until processed. Nuclei were isolated using 1 ml of cell lysis buffer (20 mM Tris pH 8, 85 mM KCl, 0.5% NP40 and 1 ×HALT protease inhibitor cocktail), resuspended in nuclear lysis buffer (10 mM Tris-HCl pH 7.5, 1% NP40, 0.5% Na deoxycholate, 0.1% SDS, 1× HALT protease inhibitor cocktail) and sonicated using optimized pulses of a Branson sonifier (1 min ON/OFF pulses for 5 cycles) for ChIP-seq libraries and S220 Covaris sonicator (settings: duty cycle 5%, intensity 6, cycles/burst 200, pulse length 60 s, 20 cycles, 8 °C) for SONO-seq input preparations. Sonications were verified for both methods using the 2100 Bioanalyzer. Immunoprecipitations were carried out by first adjusting salt concentration in sheared chromatin to 167 mM NaCl and adding antibodies (6 µ g of Sox2 antibody) and incubated for 3-4 h at 4 °C. 50 µ l Protein G dynabeads (Invitrogen) were prepared for each IP reaction by washing 2 to 3 times in ChIP dilution buffer (16.7 mM Tris-HCl pH 8.1, 167 mM NaCl, 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA) and added for one additional hour to pull-down bound chromatin. Bead complexes were washed 6 times in RIPA buffer (20 mM Tris-HCl pH 8.1, 1 mM EDTA, 140 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.1% Na deoxycholate), then twice with RIPA buffer with high salt concentration (500 mM), then twice in LiCl buffer (10 mM Tris-HCl pH 8.1, 1 mM EDTA, 1% DOC, 1% NP40, 250 mM LiCl) and twice in TE buffer. Complexes were then eluted and reverse crosslinked in 50 µ l ChIP elution buffer (10 mM Tris-HCl pH 8, 5 mM EDTA, 300 mM NaCl, 01% SDS) and 8 µ l of reverse crosslinking buffer (250 mM Tris-HCl pH 6.5, 1.25 M NaCl, 62.5 mM EDTA, 5 mg ml −1 proteinase K, 62.5 µ g ml −1 RNase A) by incubation at 65 °C for 6 h. DNA was isolated using Ampure SPRI beads and yield quantified using Qubit fluorometer.
ChIP-seq libraries were constructed from 10 ng of immunoprecipitated DNA using the NEBNext ChIP-seq library prep reagent set for Illumina (New England Biolabs), following the supplier's protocol. Briefly, purified DNA was endrepaired and dA-tailed. Following subsequent ligation of sequencing adaptors, ligated DNA was size-selected to isolate fragments in the range of 300-550 bp in length using Egels. Adaptor-ligated fragments were enriched in a 14-cycle PCR using Illumina multiplexing primers. Libraries were purified, analysed for correct size distribution using dsDNA High Sensitivity Chips on a 2100 Bioanalyzer (Agilent), pooled and submitted for single-end 50 bp Illumina GAII high-throughput sequencing. SONO-seq bioinformatics analysis. The reads were aligned to the mouse genome (mm 9) using Bowtie with the unique mapping option 39 . The smoothed tag density profiles were generated using get.smoothed.tag.density function of the SPP R package 40 with a 100-bp Gaussian kernel, a 50-bp step and library size normalization. The positions of promoters and enhancers in ES cells were obtained from a publicly available data set 41 . To access the significance of the difference in the enrichment values between CAF-1 and Renilla knockdown samples, a paired Wilcoxon rank sum test was used. ATAC-seq bioinformatics analysis. The reads were aligned to mM 9 using BWA version 0.7.8 with -q 5 -l 32 -k 2 and paired option 42 . Non-primary mapping, failed QC, duplicates and non-paired reads were filtered. If one paired-end was mapped to one chromosome and the other end was mapped to a different chromosome, the read was not included. The reads aligned to chrM were also removed. Only uniquely mapped reads were used. The read density profiles were generated using 150-bp windows with a 20-bp step and were normalized by the library size. For the comparison between Chaf1 shRNA and Renilla shRNA samples, the read density profiles were further normalized using the mean values of all annotated promoters from mm 9. For meta-analysis, the reads from Chaf1a.164 and Chaf1a.2120 knockdown samples were merged. The coordinates of promoters and enhancers in ESCs and MEFs were obtained from a publicly available data set 41 . The coordinates of the super-enhancers for the metagene plot were used from a recently published data set 43 . Each super-enhancer region (with 5-kb margins) was divided into 101 bins and the tag density signals were averaged in each bin. Significantly enriched regions were detected using Hotspot 44 with FDR = 0.01. A one-sided paired Wilcoxon rank sum test was used for the comparison in the enrichment values between CAF-1 and Renilla knockdown samples. To classify the genomic locations of the peaks (promoters, coding exons, introns, intergenic regions, 5′ UTR and 3′ UTR), the annotations for mm 9 were downloaded from UCSC (https://genome.ucsc.edu/cgi-bin/hgTables). The differential sites between CAF-1 and Renilla knockdown samples were identified using DiffBind with P = 0.05 for the consensus ATAC-seq peaks after normalization with TMM (trimmed mean normalization method) 45 . DiffBind uses statistical routines developed in edgeR 46 . A one-sided paired Wilcoxon rank sum test was used for the comparison in the enrichment values between CAF-1 and Renilla knockdown samples. Sox2 ChIP-seq bioinformatics analysis. The reads were aligned and tag densities profiles were generated as in SONO-seq analyses. The log 2 -fold enrichment profiles were generated using get.smoothed.enrichment.mle in the SPP R package. The profiles were normalized by the background-scaling method using non-enriched regions. A paired Wilcoxon rank sum test was used for the comparison in the Sox2 enrichment values between Chaf1a and Renilla knockdown samples. For Sox2 peak comparison between CAF-1 and Renilla knockdown samples, reads were first subsampled to make the sequencing depth the same for each condition (number of peaks called tends to increase for greater sequencing depth). The significantly enriched peaks compared to input were detected using the SPP find. binding.positions function with default parameters. The overlapped peaks were compared with a margin of 200 bp. For unique peaks, we first identified the peaks that were present only in one condition (CAF-1 or Renilla knockdown) and compared the enrichment values (input-subtracted tag counts) between CAF-1 and Renilla knockdown. If the ratios between the enrichment values were greater than two-fold, we considered the peaks as 'unique' for one of the conditions. We used Sox2 ChIP-seq data in ES cells from publicly available data sets 47 and analysed data in the same as described above. H3K9me3 ChIP-seq bioinformatics analyses. ChIP-seq data were mapped to the mouse genome (mm 9) with Bowtie 0.12.7 (ref. 39 ) allowing up to 3 mismatches, retaining uniquely mapping reads. To assess H3K9me3 signal distribution genome-wide, we divided the genome in 5-kb intervals, and for each interval, we calculated the ratio of RPM normalized signal in the IP and input samples. Intervals with less than 10 reads in the input samples (~10% of all) were excluded from further analyses due to low coverage. Intervals overlapping specific regions were extracted using the bedtools suite 48 . RRR annotations were obtained from ref. 29, and signal across all included 5-kb intervals was averaged. For H3K9me3 enrichment over transposable element (TE) bodies, we used the mm 10 genome version, as this release contains the most recent TE annotations. We extracted the genomic regions corresponding to TE families annotated in the mm10 RepeatMasker track in the UCSC genome browser (http://genome. ucsc.edu/), and calculated the normalized read counts in IP to input samples for each family. Due to the repetitive nature of TEs, we further validated all results considering reads that map to multiple (up to 10,000) positions in the genome, and scaling read counts by the number of valid alignments. This threshold for multiple mapping positions was chosen as it was previously shown to approximate results obtained allowing unlimited mapping positions, but at a significantly improved computation speed 49 . In all analyses, signal estimates based on uniquely mapping reads and based on reads mapping to multiple genomic positions produced similar results. Gene expression analysis using microarrays. The microarray data were pre processed using Affymetrix Expression Console version 1.3.0.187 and normalized by the RMA procedure. The limma Bioconductor package was used to select differentially expressed genes with false discover rate (FDR) ≤ 0.05 and at least two-fold change 50 . We performed functional analysis with gene set enrichment analysis (GSEA) 51 using the limma moderated t-statistic to rank the genes. Association of ATAC-seq changes with transcriptional changes. ATAC-seq peaks were separately called for CAF-1 and Renilla knockdown at days 0, 3 and 6 as described above. To determine which genes from Supplementary Table 5 may be affected by altered ATAC-seq signals, we incorporated long-range interaction data between promoters and enhancers based on ChIA-PET analysis in ES cells 52 . If there was no matched pair from the ChIA-PET tables, the regions proximal to the TSSs of genes (<4 kb) were taken. The regions were overlapped with the union ATAC-seq peaks of each conditions. For the overlapped peaks, the enrichment values (log 2 tag counts) were compared between CAF-1 and Renilla knockdown samples with two-sided paired Wilcoxon rank sum test. RNA-seq analysis of genes and transposable element bioinformatics analysis. RNA sequencing data was first pre-processed using Reaper 53 to remove any Illumina adaptor sequences and computationally depleted of ribosomal RNA sequences (GenBank identifiers: 18S, NR_003278.3; 28S, NR_003279.1; 5S, D14832.1; and 5.8S, K01367.1) using Bowtie 0.12.7 allowing three mismatches 39 . For protein-coding gene expression analyses, pre-processed data was mapped to the mouse genome (mm 10) using Bowtie 0.12.7 (ref. 39 ) allowing three mismatches, and retaining uniquely mapping reads. Mouse transcript annotations were obtained from RefSeq, and reads corresponding to the exonic regions of each gene were calculated using a custom phyton script. For overlapping genes, reads corresponding to overlapping regions were divided equally. Gene differential expression was analysed using the DESeq R package 54 .
For TE expression analyses, data was mapped to the mm 10 genome with 0 mismatches and considering reads that map to up to 10,000 genomic positions as in ChIP sequencing analyses. We then calculated the number of reads corresponding to TE regions annotated by the UCSC RepeatMasker track, scaling by the number of valid alignments for each read. Scaled reads for each TE family were summed, and normalized as RPM. Heatmaps were generated using the gplots R package, and differential expression analyses were performed using the DESeq R package 54 . Comparisons of RNA-sequencing results from analyses based on uniquely mapping reads, and based on reads mapping to multiple genomic positions, showed very similar results. Supplementary Fig. 1 for full scans). c, Quantification of data shown in Fig. 1f. d Supplementary Fig. 1 for full scans) . The same membrane was probed with anti-CAF-1 p150 and anti-CAF-1 p60 antibody to confirm knockdown (data not shown . c, Quantification of data shown in b using the geometric mean (n = 1 experiment for 3 indicated time points). d, Reprogramming efficiency of Col1a1::tetOP-miR30-tRFP-Chaf1a.164; R26-M2rtTA MEFs infected with pHAGE (Ef1a-OKSM) vector and induced with high (2 µ g ml −1 ) or low (0.2 µ g ml −1 ) doses of doxycycline for indicated number of days before scoring for Nanog + iPS cells by immunocytochemistry on day 9. e, Classification of CRISPR/Cas9-induced mutations by sequence analysis of representative iPS cell clones (wt, wild type; indel, insertion/deletion; fs, frameshift; *, point mutation). f, Western blot analysis for CAF-1 subunits p150 and p60 in 6 representative iPS cell clones after CRISPR/Cas9-induced modifications of the Chaf1a locus (see Supplementary Fig. 1 for full scans) . Wt/wt samples show unmodified wild-type control samples. 
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